title: In utero gender dimorphism of adiponectin reflects insulin sensitivity and adiposity of the fetus.
abstract: Circulating adiponectin reflects the degree of energy homeostasis and insulin sensitivity of adult individuals. Low abundance of the high molecular weight (HMW) multimers, the most active forms mediating the insulin-sensitizing effects of adiponectin, is indicative of impaired metabolic status. The increase in fetal adiponectin HMW compared with adults is a distinctive features of human neonates. To further understand the functional properties of adiponectin during fetal life, we have evaluated the associations of adiponectin with insulin sensitivity, body composition, and gender. Umbilical cord adiponectin, adiponectin complexes, and metabolic parameters were measured at term by elective cesarean delivery. The associations between adiponectin, measures of body composition, and insulin sensitivity were evaluated in relation to fetal gender in 121 singleton neonates. Higher total adiponectin concentrations in female compared with male fetuses (34.3+/-9.5 vs. 24.9+/-8.6, P<0.001) were associated with a 3.2-fold greater abundance in circulating HMW complexes (0.20+/-0.03 vs. 0.08+/-0.03, P<0.001, n=9). Adiponectin was positively correlated with neonatal fat mass (r=0.27, P<0.04) and percent body fat in female fetuses (r=0.28, P<0.03) and with lean mass in males (r=0.28, P<0.03). There was no significant correlation between cord adiponectin and fasting insulin concentrations or fetal insulin sensitivity as estimated by homeostasis model assessment of insulin resistance (HOMA-IR). The gender dimorphism for plasma adiponectin concentration and complex distribution first appears in utero. In sharp contrast to the inverse correlation found in adults, the positive relationship between adiponectin and body fat is a specific feature of the fetus.
authors.affiliation: Department of Reproductive Biology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
authors.forename: Subhabrata
authors.initials: S
authors.lastname: Basu
authors.forename: Laura
authors.initials: L
authors.lastname: Laffineuse
authors.forename: Larraine
authors.initials: L
authors.lastname: Presley
authors.forename: Judi
authors.initials: J
authors.lastname: Minium
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Catalano
authors.forename: Sylvie
authors.initials: S
authors.lastname: Hauguel-de Mouzon
mesh_terms: D052242:Adiponectin / Q000097:blood; D050154:Adiposity; D000328:Adult; D002585:Cesarean Section; D016640:Diabetes, Gestational / Q000097:blood* / Q000503:physiopathology; D005260:Female; D005312:Fetal Blood / Q000378:metabolism*; D005333:Fetus / Q000378:metabolism* / Q000503:physiopathology; D005865:Gestational Age; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D008970:Molecular Weight; D011247:Pregnancy; D012737:Sex Factors; D055815:Young Adult
chemical_list: C499918:ADIPOQ protein, human; D052242:Adiponectin